...
首页> 外文期刊>Emerging Infectious Diseases >Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08
【24h】

Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08

机译:耐Oseltamivir的甲型流感病毒(H1N1),挪威,2007-08年

获取原文

摘要

In Norway in January 2008, unprecedented levels of os-eltamivir resistance were found in 12 of 16 in. uenza viruses A (H1N1) tested. To investigate the epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007–08 season for resistance. Questionnaires from physicians pro-vided information on predisposing diseases, oseltamivir use, symptoms, and complications. Clinical data were obtained for 265 patients. In total, 183 (67.3%) of 272 viruses were oseltamivir resistant. Resistance was not associated with prior use of antiviral drugs. Symptoms and hospitalization rates did not differ for patients infected with a resistant or a susceptible virus. Oseltamivir-resistant in. uenza viruses A (H1N1) did not show diminished capability to spread in the absence of selective pressure. The ability of these viruses to sustain their fi tness and spread among persons should be considered when shaping future strategies for treating and preventing seasonal and pandemic in. uenza
机译:在2008年1月的挪威,测试的16英寸U. H1N1流感病毒中有12株对os-eltamivir的耐​​药性达到空前水平。为了调查这些病毒的流行病学和临床特征,我们使用序列分析测试了2007-08赛季以来所有可用的H1N1亚型病毒的耐药性。医生的问卷调查提供了有关易感疾病,奥司他韦的使用,症状和并发症的信息。获得了265例患者的临床数据。总计272种病毒中的183种(67.3%)对奥司他韦具有抗药性。耐药与先前使用抗病毒药物无关。感染抗药性或易感病毒的患者的症状和住院率没有差异。在没有选择压力的情况下,耐奥瑟他韦的流感病毒A(H1N1)的扩散能力没有降低。在制定未来的治疗和预防季节性和大流行性流感的策略时,应考虑这些病毒维持其适应性和在人中传播的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号